These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 8386483)
1. Ibutilide: enhanced defibrillation via plateau sodium current activation. Wesley RC; Farkhani F; Morgan D; Zimmerman D Am J Physiol; 1993 Apr; 264(4 Pt 2):H1269-74. PubMed ID: 8386483 [TBL] [Abstract][Full Text] [Related]
2. Epicardial administration of ibutilide from polyurethane matrices: effects on defibrillation threshold and electrophysiologic parameters. Labhasetwar V; Underwood T; Heil RW; Gallagher M; Langberg J; Levy RJ J Cardiovasc Pharmacol; 1994 Nov; 24(5):826-40. PubMed ID: 7532762 [TBL] [Abstract][Full Text] [Related]
3. Ibutilide Reduces Ventricular Defibrillation Threshold and Organizes Ventricular Fibrillation Activation in Canine Heart Failure Model. Zhang N; Luo Q; Jin Q; Han Y; Huang S; Wei Y; Lin C; Chen K; Shen W; Wu L Cardiovasc Drugs Ther; 2020 Jun; 34(3):323-334. PubMed ID: 32297025 [TBL] [Abstract][Full Text] [Related]
4. Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells. Lee KS J Pharmacol Exp Ther; 1992 Jul; 262(1):99-108. PubMed ID: 1320693 [TBL] [Abstract][Full Text] [Related]
5. Ionic mechanism of ibutilide in human atrium: evidence for a drug-induced Na+ current through a nifedipine inhibited inward channel. Lee KS; Lee EW J Pharmacol Exp Ther; 1998 Jul; 286(1):9-22. PubMed ID: 9655836 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. Echt DS; Black JN; Barbey JT; Coxe DR; Cato E Circulation; 1989 May; 79(5):1106-17. PubMed ID: 2469545 [TBL] [Abstract][Full Text] [Related]
7. Ibutilide decreases defibrillation threshold by the reduction of activation pattern complexity during ventricular fibrillation in canine hearts. Jin Q; Zhou J; Zhang N; Lin CJ; Pang Y; Gu G; Shen WF; Wu LQ Chin Med J (Engl); 2012 Aug; 125(15):2701-7. PubMed ID: 22931978 [TBL] [Abstract][Full Text] [Related]
8. Ibutilide for the control of refractory ventricular tachycardia and ventricular fibrillation in patients with myocardial ischemia and hemodynamic instability. Sendra-Ferrer M; Gonzalez MD J Cardiovasc Electrophysiol; 2019 Apr; 30(4):503-510. PubMed ID: 30580467 [TBL] [Abstract][Full Text] [Related]
9. Antifibrillatory effects of ibutilide in the rabbit isolated heart: mediation via ATP-dependent potassium channels. Friedrichs GS; Chi L; Black SC; Manley PJ; Oh JY; Lucchesi BR J Pharmacol Exp Ther; 1993 Sep; 266(3):1348-54. PubMed ID: 8371141 [TBL] [Abstract][Full Text] [Related]
10. The effect of newer antiarrhythmic drugs on defibrillation threshold. Tacker WA; Niebauer MJ; Babbs CF; Combs WJ; Hahn BM; Barker MA; Seipel JF; Bourland JD; Geddes LA Crit Care Med; 1980 Mar; 8(3):177-80. PubMed ID: 7363635 [TBL] [Abstract][Full Text] [Related]
11. Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-hour canine myocardial infarction: a comparative study with sotalol and encainide. Buchanan LV; Kabell G; Turcotte UM; Brunden MN; Gibson JK J Cardiovasc Pharmacol; 1992 Feb; 19(2):256-63. PubMed ID: 1376795 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of antiarrhythmic drug-induced changes in defibrillation threshold: role of potassium and sodium channel conductance. Ujhelyi MR; Schur M; Frede T; Bottorff MB; Gabel M; Markel ML J Am Coll Cardiol; 1996 May; 27(6):1534-42. PubMed ID: 8626970 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the rate dependent effects of dofetilide and ibutilide in the newborn heart. Pickoff AS; Stolfi A Pacing Clin Electrophysiol; 2001 May; 24(5):816-23. PubMed ID: 11388101 [TBL] [Abstract][Full Text] [Related]
14. Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs. Babbs CF; Yim GK; Whistler SJ; Tacker WA; Geddes LA Am Heart J; 1979 Sep; 98(3):345-50. PubMed ID: 157692 [TBL] [Abstract][Full Text] [Related]
15. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease. Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic enhancement of atrial electrical defibrillation efficacy: role of ibutilide. Khoury DS; Assar MD; Sun H J Interv Card Electrophysiol; 1997 Dec; 1(4):291-8. PubMed ID: 9869983 [TBL] [Abstract][Full Text] [Related]
19. The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock. Mehdirad AA; Carnes CA; Nelson SD Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):147-51. PubMed ID: 9990620 [TBL] [Abstract][Full Text] [Related]
20. Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization. Nabih MA; Prcevski P; Fromm BS; Lavine SJ; Elnabtity M; Munir A; Steinman RT; Meissner MD; Lehmann MH Pacing Clin Electrophysiol; 1993 Oct; 16(10):1975-83. PubMed ID: 7694244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]